Moreover, the combination of AAV vector-mediated NUPR1 shRNA expression and trifluoperazine (TFP) treatment, an anti-psychotic drug that binds to NUPR1 and is able to mimic NUPR1 deficiency in cancer cells, showed synergistic growth inhibitory activity. This evidence concerns the gene NUPR1 and cancer.